Does Episodic Heavy Drinking Redefine Risk in MASLD?

Could episodic heavy drinking be a missing risk factor accelerating fibrosis in MASLD patients? ##Reference## Yinan Su, Jennifer L. Dodge, Brian P. Lee.Episodic Heavy Drinking and Implications for Steatotic Liver Disease Nomenclature: A National Cross-Sectional Study. Clinical Gastroenterology and Hepatology.

Published on April 2, 2026.## ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information, including data visualization elements and graphics. We do not endorse any medical treatment, product, ideas, or service, including content from our industry partners. We do not associate with the views of any individual, community, organization, industry partner, or political party. Unauthorized use,…